Concord Biotech Ltd. - Research Center
543960 CONCORDBIO Group (B) BSE data
Results
|
Half yearly
|
Statement
|
|
More
|
|
Half yearly results in brief
(Rs crore)
|
Sep ' 23 |
Sep ' 22 |
Sales |
457.17 |
339.90 |
Operating profit |
191.34 |
102.55 |
Interest |
1.59 |
2.15 |
Gross profit |
204.53 |
114.26 |
EPS (Rs) |
12.71 |
6.27 |
Half yearly
results in details
|
Sep ' 23 |
Sep ' 22 |
Other income |
14.78 |
13.86 |
Stock adjustment |
-10.28 |
-17.93 |
Raw material |
81.48 |
80.37 |
Power and fuel |
- |
- |
Employee expenses |
58.42 |
54.05 |
Excise |
- |
- |
Admin and selling expenses |
- |
- |
Research and development expenses |
- |
- |
Expenses capitalised |
- |
- |
Other expenses |
136.22 |
120.87 |
Provisions made |
- |
- |
Depreciation |
26.34 |
26.08 |
Taxation |
45.23 |
22.64 |
Net profit / loss |
132.96 |
65.55 |
Extra ordinary item |
- |
- |
Prior year adjustments |
- |
- |
Equity capital |
10.46 |
10.46 |
Equity dividend rate |
- |
- |
Agg.of non-prom. shares (Lacs) |
- |
- |
Agg.of non promotoholding (%) |
- |
- |
OPM (%) |
41.85 |
30.17 |
GPM (%) |
43.34 |
32.30 |
NPM (%) |
28.17 |
18.53 |